treatment. The API system in the field of Alzheimer's disease has become a quality supplier to many pharmaceutical companies around the world, and has established long-term cooperative relationships with many famous domestic and foreign pharmaceutical companies to achieve win-win cooperation.

　　Lixin Pharmaceutical focuses on the in-depth research, development and production of specialty raw materials and major diseases, and adheres to the scientific, rigorous and standardized corporate culture, advocating the spirit of innovation, focusing on safety, environmental protection, low consumption and high quality original technology. The development and application of the company has more than 30 international invention patents in China, the United States, Europe and other regions, and has formed an independent independent intellectual property system. Lixin Pharmaceutical not only provides high-quality raw materials and key intermediates, but also provides integrated technical solutions including raw material process development, quality research, crystal and particle size research, and standard and impurity reference products according to customer needs. . The company has obtained 3 US DMF documents, 3 CEP certificates, 5 CFDA new drug certificates and 8 domestic GMP certificates. At the same time, more than 20 products are being established, R&D and domestic and foreign registration. It has laid a solid foundation for the company's rapid and efficient sustainable development.